OWC Pharmaceutical Research Corp (OWCP)

[stockfan100]

So Fantasyland Proof!

Multiple Myeloma – 23 pages of complete study design, methods, procedures, dosages, result, and more.

The link to OWCP’s original registration at USPTO is included in the link below.

Abstract

The present invention discloses a cytotoxic cocktail comprising;(a) a therapeutically effective amount of at least one cannabinoid selected from the group consisting of; cannobidiol (CBD) or a derivative thereof, Tetrahydrocannabinol (THC) or a derivative thereof, an any combination thereof nf (b) at least one therapeutic agent selected from the group consisting of: bortezomib (BTZ), carfilzomib (CFZ), lenalidomide (LEN), dexamethasone (DEX), melphalan (MEL) and doxorubicin (DOXO). In a core embodiment the cocktail is conferring a synergistic effect with respect to inhibition or cytotoxicity of multiple myeloma (MM) cells, relative to said at least one therapeutic agent selected from the group consisting of: BZ, CFZ, DEX, MEL, DOXO and said CBD and THC, administered separately in similar concentration.

Novel cannabinoid combination therapies for multiple myeloma (mm) (23 pages)
https://www.freshpatents.com/-dt20180705ptan20180185324.php